Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren Syndrome
- PMID: 29369232
- PMCID: PMC6046269
- DOI: 10.1097/ICL.0000000000000448
Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren Syndrome
Abstract
Objective: To survey ophthalmologists about current practice patterns regarding the evaluation of dry eye patients and referrals for a Sjogren syndrome (SS) workup.
Methods: An online survey was sent to ophthalmologists affiliated with the Scheie Eye Institute or Wills Eye Hospital using REDCap in August 2015. Descriptive statistics were used to summarize the data.
Results: Four hundred seventy-four survey invitations were sent out and 101 (21%) ophthalmologists completed the survey. The common traditional dry eye test performed was corneal fluorescein staining (62%) and the most common newer dry eye test performed was tear osmolarity (18%). Half of respondents (51%) refer fewer than 5% of their dry eye patients for SS workups, with 18% reporting that they never refer any patients. The most common reasons for referrals included positive review of systems (60%), severe dry eye symptoms (51%) or ocular signs (47%), or dry eye that is refractory to treatment (42%). The majority (83%) felt that there is a need for an evidence-based standardized screening tool for dry eye patients to decide who should be referred for evaluation for SS.
Conclusions: Ophthalmologists continue to prefer the use of traditional dry eye tests in practice, with the most common test being corneal fluorescein staining. There is an underreferral of dry eye patients for SS workups, which is contributing to the continued underdiagnosis of the disease. Most respondents felt that there was a need for an evidence-based standardized screening tool to decide which dry eye patients should be referred for SS evaluations.
Conflict of interest statement
Vatinee Y. Bunya received a grant from Bausch & Lomb for an unrelated study. Gui-shuang Ying serves as a consultant for Janssen R & D and Kanghong Biotech Inc. Mina Massaro-Giordano serves as a consultant for Glaxo Smith Kline, and is an investor in PRN. Kristin M. Hammersmith serves on the speaker's bureau for Shire. Christopher J. Rapuano serves as a consultant for Aerie, Allergan, and TearLab. He also is on the speaker's bureau and is a consultant for Bausch & Lomb, Bio-Tissue, and Shire. For the remaining authors none were declared.
References
-
- The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf. 2007;5(2):75–92. - PubMed
-
- Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15(3):276–83. - PubMed
-
- Barabino S, Labetoulle M, Rolando M, Messmer EM. Understanding Symptoms and Quality of Life in Patients With Dry Eye Syndrome. Ocul Surf. 2016;14(3):365–76. - PubMed
-
- Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334–65. - PubMed
-
- Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15(3):539–74. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
